|
MCTS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.023860E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.097200E-03 |
| Normal-vs-Stage2 |
4.677800E-01 |
| Normal-vs-Stage3 |
5.370100E-04 |
| Normal-vs-Stage4 |
2.241700E-04 |
| Stage1-vs-Stage2 |
1.528220E-01 |
| Stage1-vs-Stage3 |
1.636780E-01 |
| Stage1-vs-Stage4 |
8.014400E-02 |
| Stage2-vs-Stage3 |
2.419800E-02 |
| Stage2-vs-Stage4 |
1.458040E-02 |
| Stage3-vs-Stage4 |
4.992800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.220000E-04 |
| Normal-vs-AfricanAmerican |
1.145030E-01 |
| Normal-vs-Asian |
5.407600E-02 |
| Caucasian-vs-AfricanAmerican |
5.932800E-01 |
| Caucasian-vs-Asian |
4.233400E-01 |
| AfricanAmerican-vs-Asian |
9.581400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.017700E-03 |
| Normal-vs-Female |
1.160630E-03 |
| Male-vs-Female |
8.891600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.623500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.761890E-03 |
| Normal-vs-Age(61-80Yrs) |
7.098000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.891700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.746200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.491600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.795000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.527600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.206600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.390000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.230500E-02 |
| Classical-VS-Follicular |
6.638200E-02 |
| Classical-VS-Other |
6.062400E-01 |
| Classical-VS-Normal |
1.321320E-03 |
| Tall-VS-Follicular |
1.280510E-03 |
| Tall-VS-Other |
8.540600E-01 |
| Tall-VS-Normal |
1.93813000000098E-05 |
| Follicular-VS-Other |
2.767800E-01 |
| Follicular-VS-Normal |
3.808000E-01 |
| Other-VS-Normal |
2.012000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.318300E-02 |
| Normal-vs-N1 |
4.583100E-03 |
| N0-vs-N1 |
1.644400E-01 |
|
|
